CD4-dependent potentiation of a high molecular weight-melanoma-associated antigen-specific CTL response elicited in HLA-A2/Kb transgenic mice

Liaomin Peng, Eric Ko, Wei Luo, Xinhui Wang, Protul A. Shrikant, Soldano Ferrone

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The human high m.w.-melanoma-associated Ag (HMW-MAA) is an attractive target for the immunotherapy of melanoma, due to its relatively high expression in a high percentage of melanoma lesions and its restricted distribution in normal tissues. Active immunization with HMW-MAA mimics has been previously shown to induce a HMW-MAA-specific, T cell-dependent Ab response associated with an apparent clinically beneficial effect in advanced melanoma patients. Although T cells play an important role in controlling tumor growth, only limited information is available to date about the induction of HMW-MAA-specific CTL. In this report, we show that immunization of HLA-A2/Kb transgenic mice with HMW-MAA cDNA-transfected syngeneic dendritic cells elicited a CD8+ CTL response specific for HMW-MAA peptides with HLA-A2 Ag-binding motifs. The elicited CTL lysed HLA-A2+HMW-MAA+ melanoma cells in vitro, and mouse HLA-A2/Kb cells pulsed with HMW-MAA-derived peptides in vitro and in vivo. Although this CTL response could be generated in the absence of CD4+ T cell help, harnessing CD4 + T cell help in a noncognate Ag-specific manner with the polyclonal activator staphylococcal enterotoxin A augmented the CTL response. These results imply that dendritic cell-based immunization, in combination with CD4 + T cell help, represents an effective strategy to implement T cell-based immunotherapy targeting HMW-MAA in patients with HMW-MAA-bearing tumors.

Original languageEnglish (US)
Pages (from-to)2307-2315
Number of pages9
JournalJournal of Immunology
Volume176
Issue number4
StatePublished - Feb 15 2006
Externally publishedYes

Fingerprint

HLA-A2 Antigen
Transgenic Mice
Melanoma
T-Lymphocytes
HMW-MAA
Immunotherapy
Dendritic Cells
Immunization
Peptides
Normal Distribution

ASJC Scopus subject areas

  • Immunology

Cite this

CD4-dependent potentiation of a high molecular weight-melanoma-associated antigen-specific CTL response elicited in HLA-A2/Kb transgenic mice. / Peng, Liaomin; Ko, Eric; Luo, Wei; Wang, Xinhui; Shrikant, Protul A.; Ferrone, Soldano.

In: Journal of Immunology, Vol. 176, No. 4, 15.02.2006, p. 2307-2315.

Research output: Contribution to journalArticle

Peng, Liaomin ; Ko, Eric ; Luo, Wei ; Wang, Xinhui ; Shrikant, Protul A. ; Ferrone, Soldano. / CD4-dependent potentiation of a high molecular weight-melanoma-associated antigen-specific CTL response elicited in HLA-A2/Kb transgenic mice. In: Journal of Immunology. 2006 ; Vol. 176, No. 4. pp. 2307-2315.
@article{b10167daebf64c4298a4506119732e0b,
title = "CD4-dependent potentiation of a high molecular weight-melanoma-associated antigen-specific CTL response elicited in HLA-A2/Kb transgenic mice",
abstract = "The human high m.w.-melanoma-associated Ag (HMW-MAA) is an attractive target for the immunotherapy of melanoma, due to its relatively high expression in a high percentage of melanoma lesions and its restricted distribution in normal tissues. Active immunization with HMW-MAA mimics has been previously shown to induce a HMW-MAA-specific, T cell-dependent Ab response associated with an apparent clinically beneficial effect in advanced melanoma patients. Although T cells play an important role in controlling tumor growth, only limited information is available to date about the induction of HMW-MAA-specific CTL. In this report, we show that immunization of HLA-A2/Kb transgenic mice with HMW-MAA cDNA-transfected syngeneic dendritic cells elicited a CD8+ CTL response specific for HMW-MAA peptides with HLA-A2 Ag-binding motifs. The elicited CTL lysed HLA-A2+HMW-MAA+ melanoma cells in vitro, and mouse HLA-A2/Kb cells pulsed with HMW-MAA-derived peptides in vitro and in vivo. Although this CTL response could be generated in the absence of CD4+ T cell help, harnessing CD4 + T cell help in a noncognate Ag-specific manner with the polyclonal activator staphylococcal enterotoxin A augmented the CTL response. These results imply that dendritic cell-based immunization, in combination with CD4 + T cell help, represents an effective strategy to implement T cell-based immunotherapy targeting HMW-MAA in patients with HMW-MAA-bearing tumors.",
author = "Liaomin Peng and Eric Ko and Wei Luo and Xinhui Wang and Shrikant, {Protul A.} and Soldano Ferrone",
year = "2006",
month = "2",
day = "15",
language = "English (US)",
volume = "176",
pages = "2307--2315",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "4",

}

TY - JOUR

T1 - CD4-dependent potentiation of a high molecular weight-melanoma-associated antigen-specific CTL response elicited in HLA-A2/Kb transgenic mice

AU - Peng, Liaomin

AU - Ko, Eric

AU - Luo, Wei

AU - Wang, Xinhui

AU - Shrikant, Protul A.

AU - Ferrone, Soldano

PY - 2006/2/15

Y1 - 2006/2/15

N2 - The human high m.w.-melanoma-associated Ag (HMW-MAA) is an attractive target for the immunotherapy of melanoma, due to its relatively high expression in a high percentage of melanoma lesions and its restricted distribution in normal tissues. Active immunization with HMW-MAA mimics has been previously shown to induce a HMW-MAA-specific, T cell-dependent Ab response associated with an apparent clinically beneficial effect in advanced melanoma patients. Although T cells play an important role in controlling tumor growth, only limited information is available to date about the induction of HMW-MAA-specific CTL. In this report, we show that immunization of HLA-A2/Kb transgenic mice with HMW-MAA cDNA-transfected syngeneic dendritic cells elicited a CD8+ CTL response specific for HMW-MAA peptides with HLA-A2 Ag-binding motifs. The elicited CTL lysed HLA-A2+HMW-MAA+ melanoma cells in vitro, and mouse HLA-A2/Kb cells pulsed with HMW-MAA-derived peptides in vitro and in vivo. Although this CTL response could be generated in the absence of CD4+ T cell help, harnessing CD4 + T cell help in a noncognate Ag-specific manner with the polyclonal activator staphylococcal enterotoxin A augmented the CTL response. These results imply that dendritic cell-based immunization, in combination with CD4 + T cell help, represents an effective strategy to implement T cell-based immunotherapy targeting HMW-MAA in patients with HMW-MAA-bearing tumors.

AB - The human high m.w.-melanoma-associated Ag (HMW-MAA) is an attractive target for the immunotherapy of melanoma, due to its relatively high expression in a high percentage of melanoma lesions and its restricted distribution in normal tissues. Active immunization with HMW-MAA mimics has been previously shown to induce a HMW-MAA-specific, T cell-dependent Ab response associated with an apparent clinically beneficial effect in advanced melanoma patients. Although T cells play an important role in controlling tumor growth, only limited information is available to date about the induction of HMW-MAA-specific CTL. In this report, we show that immunization of HLA-A2/Kb transgenic mice with HMW-MAA cDNA-transfected syngeneic dendritic cells elicited a CD8+ CTL response specific for HMW-MAA peptides with HLA-A2 Ag-binding motifs. The elicited CTL lysed HLA-A2+HMW-MAA+ melanoma cells in vitro, and mouse HLA-A2/Kb cells pulsed with HMW-MAA-derived peptides in vitro and in vivo. Although this CTL response could be generated in the absence of CD4+ T cell help, harnessing CD4 + T cell help in a noncognate Ag-specific manner with the polyclonal activator staphylococcal enterotoxin A augmented the CTL response. These results imply that dendritic cell-based immunization, in combination with CD4 + T cell help, represents an effective strategy to implement T cell-based immunotherapy targeting HMW-MAA in patients with HMW-MAA-bearing tumors.

UR - http://www.scopus.com/inward/record.url?scp=32044474901&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=32044474901&partnerID=8YFLogxK

M3 - Article

C2 - 16455987

AN - SCOPUS:32044474901

VL - 176

SP - 2307

EP - 2315

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 4

ER -